Dispersin B Research Protocols: Biofilm Assays, Storage, and Activity Optimization

Overview

Dispersin B is a glycoside hydrolase enzyme used in research for studying PNAG-dependent biofilm disruption. This guide provides practical protocols for researchers working with Dispersin B in laboratory settings.

> Research Use Only: Dispersin B is sold exclusively for laboratory research. It is not intended for human or animal therapeutic use.

Enzyme Handling & Storage

- Storage temperature: -20°C (lyophilized) or -80°C (solution form) for long-term storage - Working aliquots: Store at 4°C for up to 2 weeks; avoid repeated freeze-thaw cycles - Buffer compatibility: Active in PBS, sodium acetate buffer (pH 5.5–6.0), and HEPES buffer - Optimal pH: 5.5–6.0 for maximum enzymatic activity - Temperature: 37°C for in vitro biofilm assays

Standard Biofilm Disruption Assay Protocol

Materials

- 96-well polystyrene microtiter plates - Bacterial culture (PNAG-producing organism, e.g., S. epidermidis RP62A) - Dispersin B (research grade, ≥95% purity) - Crystal violet staining solution (0.1% in water) - Acetic acid (33%) for crystal violet solubilization

Protocol

1. Biofilm formation: Inoculate wells with bacterial suspension (OD600 = 0.05) in tryptic soy broth + 0.5% glucose; incubate 24h at 37°C static
2. Washing: Remove planktonic cells by washing 3× with PBS; blot dry
3. Dispersin B treatment: Add Dispersin B (25–100 μg/mL in PBS) to biofilm-coated wells; incubate 1h at 37°C
4. Washing: Remove dispersed cells and enzyme by washing 3× with PBS
5. Crystal violet staining: Add 0.1% crystal violet; incubate 15 min at RT; wash 3× with water; dry
6. Quantification: Solubilize with 33% acetic acid; read absorbance at 595 nm

Expected Results

- 25 μg/mL Dispersin B: 40–60% biofilm reduction (strain-dependent) - 100 μg/mL Dispersin B: 70–90% biofilm reduction in PNAG-positive strains - No significant activity against PNAG-negative strains (negative control validation)

Combination Antimicrobial Protocol

1. Form biofilm as above (24h)
2. Treat with Dispersin B (50–100 μg/mL) for 1h
3. Without washing, add antibiotic at 1×, 4×, and 16× MIC concentrations
4. Incubate additional 24h
5. Assess viability by CFU counting or resazurin assay

Positive Control Organisms

- Staphylococcus epidermidis RP62A (ATCC 35984) — high PNAG producer, standard reference strain - Staphylococcus aureus MN8 — PNAG-positive clinical isolate

Negative Control Organisms

- Pseudomonas aeruginosa PAO1 — alginate-based biofilm, Dispersin B-insensitive

---

This guide is for scientific reference only. All compounds are for research use only and not for human or animal consumption.

See Also: Dispersin B Research Overview · Biofilm Research Methods Overview · Antibiofilm Peptide Strategies in Research